|
GuidelineStat™
Managing Chronic Myelogenous Leukemia in the Clinical Setting
GuidelineStat™ Managing Chronic Myelogenous Leukemia (CML) in the Clinical Setting
is a CME initiative developed in conjunction with leading experts
from The University of Texas M.D. Anderson Cancer Center,
that provides evidence-based guideline content for the treatment and management of CML.
This learning activity has been designated for a maximum of 1.00 AMA PRA Category 1 Credits™.
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.
After reviewing this module, the participant will be better able to:
- Recognize the importance of treating patients with CML who experience a suboptimal response according to current practice guidelines
- Identify patients with CML who have a suboptimal response to treatment
- Formulate an alternative treatment plan for patients whose first-line therapy has failed or who have had a suboptimal response to first-line therapy
|
Content Highlights
|
|
Editorial Faculty
Elias Jabbour, MD
Assistant Professor Department of Leukemia
The University of Texas, M.D. Anderson Cancer Center
Houston, Texas
Susan O'Brien, MD
Professor Department of Leukemia
The University of Texas, M.D. Anderson Cancer Center
Houston, Texas
|
This educational activity was made possible through an unrestricted educational grant from:
|